biotech binary events | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
biotech binary events

An SI Board Since March 2003

Posts	SubjectMarks	Bans
295	36	0

Emcee: dalroi	Type: Moderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
70	>> There was an abstract as ASCO this year giving some background on the s	Icebrg	-	8/9/2003
69	Data Safety Monitoring Board also has power to stop trial early IF there is clea	Miljenko Zuanic	-	8/9/2003
68	There was an abstract as ASCO this year giving some background on the stratifica	Icebrg	-	8/9/2003
67	>>One can speculate: To good to be true? Or there is something?>> M	Icebrg	-	8/9/2003
66	One can speculate: To good to be true? Or there is something?	Miljenko Zuanic	-	8/8/2003
65	This is supposed to be an antagonist (without the flare problems). All approved	dalroi	-	8/7/2003
64	Stefaan >>if you whish i could call them tomorrow if you whish any specif	Icebrg	-	8/7/2003
63	Erik if you whish i could call them tomorrow if you whish any specifique questi	dalroi	-	8/7/2003
62	Stefaan Here is one for you. Do you have any comments with regard to Solvay/Cet	Icebrg	-	8/7/2003
61	A month later, and still waiting for the Neovastat news. There is some discussi	nigel bates	-	8/6/2003
60	So might the Crestor AC tomorrow, at least to Shinogi.	keokalani'nui	-	7/8/2003
59	Looks like insurance policy, not good but it does not means that should be bad.	Miljenko Zuanic	-	7/8/2003
58	This will be very interesting binary event.	Miljenko Zuanic	-	7/8/2003
57	AELA trial still ongoing, but this hardly inspires confidence - <i>Qu	nigel bates	-	7/8/2003
56	CV Therapeutics Announces FDA Advisory Committee to Review Ranexa(TM) In Septemb	keokalani'nui	-	7/7/2003
55	ELN (off 25% this morning), if they file / do not file accounts by the end of Ju	nigel bates	-	6/26/2003
54	ESPR has been on quite a tear lately, so I imagine the Street is pricing in good	tuck	-	6/24/2003
53	One article (if you need copy let me know) and two link of interest. Note that	Miljenko Zuanic	-	6/5/2003
52	Re IP, a quick search turns up these: PAT. NO. Title 1 6,506,414 Low molecular	nigel bates	-	6/5/2003
51	<i>historic survival rates for metastatic disease prior to the availabilit	Biomaven	-	6/5/2003
50	<i>Thus on one of the subgroups with poorest prognosis, with median surviv	nigel bates	-	6/5/2003
49	<i>However, they did not say anything about group (inside risk factors) wh	Biomaven	-	6/5/2003
48	Peter, this are "comprehensive prognostic system of pretreatment clinica	Miljenko Zuanic	-	6/4/2003
47	The trial started in 04/00. The mid-point of enrollment was 05/01. PR said that	Biomaven	-	6/4/2003
46	<<For the patients in the trial, 10 months is the company's estimate o	Miljenko Zuanic	-	6/4/2003

Go to reply# or date (mm/dd/yy):